Superficial Bladder Urothelial Carcinoma
NCI Definition: An infiltrating urothelial carcinoma of the bladder that has not invaded into the bladder muscularis propria. 
There are 2 clinical trials for superficial bladder urothelial carcinoma, of which 2 are open and 0 are completed or closed. Of the trials that contain superficial bladder urothelial carcinoma as an inclusion criterion, 1 is phase 2 (1 open) and 1 is phase 3 (1 open).
Cisplatin, gemcitabine, and balstilimab are the most common interventions in superficial bladder urothelial carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.